Management of Rhabdomyolysis
Immediately initiate aggressive intravenous fluid resuscitation with isotonic saline targeting a urine output of 300 mL/hour to prevent acute kidney injury, which is the most critical intervention in rhabdomyolysis management. 1
Immediate Fluid Resuscitation
Aggressive IV fluid administration is the cornerstone of treatment and must be started without delay. 1 Early initiation is critical, as delayed treatment significantly increases the risk of acute kidney injury. 2, 1
- For severe rhabdomyolysis (CK >15,000 IU/L): Administer more than 6L of fluid per day 2, 1
- For moderate cases: Administer 3-6L per day 2, 1
- Target urine output: Maintain at least 300 mL/hour to facilitate myoglobin clearance and prevent renal tubular obstruction 1, 3
- Monitor closely for fluid overload, particularly in patients with cardiac or renal compromise 1
The large volume requirements reflect the need to rapidly clear myoglobin from the circulation before it causes tubular obstruction and acute tubular necrosis. 3, 4
Discontinue All Causative Agents Immediately
Stop all medications and supplements that may have contributed to rhabdomyolysis as soon as the diagnosis is suspected. 2, 1
- Statins and other prescription medications must be discontinued immediately 2, 1
- Dietary supplements to discontinue: red yeast rice (containing lovastatin), creatine monohydrate, wormwood oil, licorice, and Hydroxycut 2, 1
- In anesthesia settings: Avoid succinylcholine and inhaled anesthetics in at-risk populations 1
Electrolyte Monitoring and Correction
Check electrolyte panels every 6-12 hours in severe cases, with particular attention to potassium levels. 1
- Repeated bioassessment should include: plasma myoglobin, CK, and potassium measurements 2
- Correct significant hyperkalemia immediately, as it can precipitate cardiac arrhythmias and arrest 1
- Monitor and correct: hypocalcemia and hyperphosphatemia 1
- Assess for metabolic acidosis via arterial blood gas, which commonly occurs in severe cases 2, 1
Hyperkalemia is particularly dangerous as it can lead to life-threatening cardiac complications including pulseless electrical activity and cardiac arrest. 1
Compartment Syndrome Surveillance
Maintain high suspicion for compartment syndrome, which can both cause and complicate rhabdomyolysis. 2, 1
- Early signs to monitor: pain, tension, paresthesia, and paresis 2, 1
- Late signs indicating irreversible damage: pulselessness and pallor 2, 1
- Perform early fasciotomy when:
Missing compartment syndrome in traumatic or severe exertional cases can lead to irreversible muscle and nerve damage. 1
Pain Management Algorithm
Use acetaminophen as first-line analgesic at 500-1000 mg (maximum 4-6 grams daily) to avoid nephrotoxic effects. 2, 1
- Avoid all NSAIDs (ibuprofen, ketoprofen, diclofenac, naproxen, mefenamic acid) due to gastrointestinal and renal toxicity 2, 1
- For severe pain unresponsive to acetaminophen:
- In patients with established acute kidney injury (eGFR <30 mL/min):
Renal Replacement Therapy Indications
Consider renal replacement therapy for specific complications that cannot be managed medically. 1
- Indications for RRT:
- Refractory hyperkalemia
- Severe metabolic acidosis
- Progressive acute kidney injury despite adequate hydration 1
- Initiate RRT if: CK remains persistently elevated despite 4 days of adequate hydration 1
- Consider discontinuation when: urine output recovers adequately (>100 mL/day) 1
Duration of IV Fluid Therapy
Continue intravenous fluids until CK levels decrease to less than 1,000 U/L. 3
This endpoint indicates that active muscle breakdown has ceased and the risk of ongoing myoglobin-induced renal injury has substantially decreased. 3, 4
Critical Pitfalls to Avoid
- Do not delay fluid resuscitation, as this is associated with higher risk of acute kidney injury and worse outcomes 1
- Do not use inadequate fluid volumes, which may fail to prevent renal complications 1
- Do not miss compartment syndrome, particularly in traumatic or severe exertional cases 1
- Do not use NSAIDs for pain management due to nephrotoxic effects in patients already at high risk for acute kidney injury 2, 1
Special Considerations for Statin-Induced Cases
For statin-associated rhabdomyolysis, consider nonstatin therapies for continued lipid management after discontinuation. 2
- Alternative lipid-lowering agents: ezetimibe, PCSK9 inhibitors, or bempedoic acid 2
- If statins are eventually needed: use hydrophilic statins (fluvastatin, pravastatin) as they have fewer metabolic interactions 2
- Genetic risk factors: SLCO1B1 gene mutations increase risk of statin-induced rhabdomyolysis 2